Lv2
178 积分 2024-05-27 加入
Using Homeostatic Model Assessment of Insulin Resistance to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease Risk Stratification in Individuals with Type 2 Diabetes from Primary Care and Endocrinology Settings
17小时前
求助中
Current therapeutic landscape and future treatment perspectives of MASH
1个月前
已完结
521 ALT, FIBROSCAN VCTE, AND FIBROSCAN CAP AS PREDICTIVE MARKERS OF RESMETIROM BIOPSY RESPONSE
1个月前
已关闭
521 ALT, FIBROSCAN VCTE, AND FIBROSCAN CAP AS PREDICTIVE MARKERS OF RESMETIROM BIOPSY RESPONSE
1个月前
已关闭
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis
1个月前
已完结
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
1个月前
已完结
The dynamic spectrum of steatotic liver disease: the global perspective
1个月前
已完结
Plasma proteomics framework predicts metabolic dysfunction-associated steatotic liver disease up to 16 years before onset
2个月前
已完结
Single cell-resolved transcriptional dynamics of human subcutaneous adipose tissue during lifestyle- and bariatric surgery-induced weight loss
8个月前
已完结
The role of interferon-γ in cardiovascular disease: an update
1年前
已完结
皖公网安备34019202002308
